Diabetes and cardiometabolic DTC brands must build clinical trust, withstand claim scrutiny, and guide people through eligibility – all while feeling as simple as a consumer product. We develop the brand, funnel, and compliance posture together so the launch stands up to real scrutiny.
The Challenge
Standard consumer launch tactics clash with claim rules from day one
The bold, benefit-forward messaging that powers a normal DTC launch can imply your product treats or reverses a condition, which is a regulatory problem in this category. Founders who launch with a consumer playbook often have to pull creative and rebuild mid-flight. The brand and its claims have to be designed to be persuasive and defensible from the first asset, not fixed after launch.
The conversion bottleneck is trust, not price or convenience
People do not hand over their health to a brand they do not believe, so a slick funnel with no clinical credibility converts poorly regardless of offer. In cardiometabolic health, the buyer is evaluating whether you are legitimate, safe, and evidence-backed before anything else. A launch that leads with convenience and hides the credibility fails at the exact moment of decision.
Friction in eligibility and onboarding destroys launch momentum
Unlike a consumer purchase, going direct often requires eligibility checks, health intake, or clinical screening, and every added step leaks the demand a launch worked hard to create. Teams that bolt these steps on after building the funnel watch conversion collapse at the gate. Designing the eligibility path as part of the launch experience is what preserves the momentum.
A launch spike without retention is a costly event, not a business
Cardiometabolic outcomes and revenue depend on people staying engaged for months, so a launch that acquires a wave of patients who churn immediately proves nothing. Many launches over-invest in the spike and under-invest in the first 90 days of the patient relationship. Building activation and retention into the launch is what turns it into a durable channel.
How We Help
We develop the brand alongside its claim posture. Positioning, voice, and creative are built to be persuasive and defensible – benefit-forward where permitted and evidence-backed where necessary – so the launch does not have to choose between conversion and staying within the rules. This forms the basis of the [growth strategy](/services/strategy/) guiding everything downstream.
We put credibility first because trust is the true conversion lever. Rather than burying them, the launch brings clinical legitimacy, evidence, and safety forward early, helping skeptical health buyers move beyond the "is this real" question before we ask them to decide. Building credibility into the brand is what enables the funnel to convert.
Through our [product](/services/product/) practice, we create the funnel and eligibility path as a single experience. Health intake, eligibility, and screening are ordered to minimize drop-off at every gate, ensuring the demand generated by the launch reaches enrollment instead of disappearing at an awkward qualification step.
Activation and retention are part of the launch plan from the outset, not deferred to a later phase. We design the first 90 days of the patient relationship alongside acquisition, turning launch demand into engaged, retained patients instead of a spike followed by churn. That is what turns DTC into a business rather than an event.
From launch day, our [measurement](/services/measurement/) practice connects spend and channels to activated, retained patients, allowing you to identify what works quickly and reallocate accordingly. A launch begins a learning loop; it is not a one-off push.
We do not put a polished funnel live and simply hope. We launch a brand that builds trust, a funnel that gets through eligibility, and a retention plan that makes acquiring the demand worthwhile.
What we deliver
- Brand positioning and voice designed to be persuasive and claim-defensible
- A credibility-led launch narrative that surfaces evidence and safety early
- A funnel and eligibility path designed as a single low-friction experience
- An activation and retention plan for the first 90 days built into the launch
- Compliant launch creative across channels that avoids campaign rejection
- Launch-day measurement tying channels to activated, retained patients
Trust and eligibility—not offer and convenience—determine whether a diabetes or cardiometabolic DTC launch succeeds. The brands that break through build credibility into the message and qualification into the funnel, ensuring the demand they generate survives the point when a skeptical health buyer makes a decision.
Our Methodology
Our 90-day sprint moves a diabetes or cardiometabolic brand from launch strategy to an operating, measured direct-to-patient engine. Days 1-30 establish the foundation: we develop positioning and claim posture in tandem, define a credibility-led narrative, and map eligibility and onboarding so qualification is accounted for in the funnel from the beginning. This phase concludes with a launch strategy and brand system.
Days 31-60 are focused on building the launch. We create compliant creative, build the funnel and eligibility flow as one cohesive experience, and plan activation for the opening weeks of the patient relationship. Before any media dollars are spent, everything is instrumented through downstream enrollment and retention.
Days 61-90 are for launching, learning, and handoff. We go live, evaluate channel and funnel performance using activated-patient metrics, address friction wherever the funnel leaks, and document the playbook for your team to scale. Since launch starts a learning loop, the sprint establishes ongoing iteration rather than creating one flashy moment.
How We Work
During the first 30 days, we collaborate with your founder, clinical, and regulatory leads because the brand, claims, and eligibility path must all align before launch. Expect focused sessions covering positioning, claim boundaries, and funnel design.
Days 30-60 shift into the build. Instead of delivering a brand deck and an unrelated funnel, we create compliant assets, an integrated funnel-and-eligibility journey, and an activation plan for the early patient relationship, with everything instrumented to enrollment and retention.
Days 60-90 focus on launch and iteration. We go live, assess results against activated-patient metrics, remove what is not performing, and hand over the playbook and dashboards. Because retention validates the model, most engagements last 4-6 months, allowing us to see whether the first cohorts stay or churn and adjust accordingly.
The team consists of a brand and growth strategist responsible for positioning and the launch plan, a creative resource developing compliant assets, a product-minded resource designing the funnel and eligibility flow, and a measurement resource connecting everything to retained patients.
- A brand that earns clinical trust at the moment of decision
- Claim-defensible creative that avoids mid-launch rebuilds
- A funnel that survives eligibility and screening without leaking demand
- Activation and retention built into the launch, not bolted on
- Fast channel learning tied to activated-patient economics
If your diabetes & cardiometabolic health company needs dtc brand launch leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What is the cost of a DTC brand launch for a diabetes or cardiometabolic company?
A complete launch engagement – covering brand, funnel, creative, and measurement – typically costs $25K-$55K/month during the build and launch window, excluding media spend. The exact amount depends on scope and the level of clinical and regulatory coordination needed. Pricing is based on the depth of brand, funnel, and compliance work, not a set number of assets. Since the launch is built around retained patients, the investment is evaluated against durable acquisition economics rather than launch-week volume.
What makes a health DTC launch different from a typical consumer launch?
Messaging that drives a typical launch can cause claim issues in this category. Trust – not price or convenience – is the primary conversion lever, and conversion often involves eligibility or screening that a consumer purchase does not. As a result, the brand, funnel, and compliance posture must be developed together. Applying a standard consumer playbook here usually leads to it being pulled and rebuilt in the middle of launch.
How can you launch bold messaging while staying within claim rules?
From the first asset, we shape positioning and creative to persuade within the claim boundaries, prioritizing credibility and evidence where required and using benefit-forward language where permitted. Claim review is integrated into brand development rather than left as a final gate that strips it down. This lets the launch convert without causing the regulatory issue that requires a rebuild.
How soon does a launch reveal whether it is working?
Initial channel and funnel signals emerge in the first few weeks, but the meaningful answer – whether acquired patients activate and remain – takes the first 60-90 days as early cohorts progress through onboarding and retention. We instrument those downstream events from launch day, so you do not have to rely on lagging signals. That is why the engagement lasts long enough to observe how the first cohorts behave.
How do you prevent a launch from becoming a spike followed by churn?
We plan activation and the first 90 days of the patient relationship together with acquisition, allowing demand to become engaged patients instead of a wave that quickly leaves. Retention is instrumented at launch, so channels bringing in patients who churn are cut rather than scaled. We approach the launch as the beginning of a durable channel, not a one-off event.
What does the process of starting a launch involve?
We start by developing positioning and claim posture in parallel, establishing the credibility-led narrative, and mapping eligibility and onboarding so qualification shapes the funnel design. The result is a launch strategy and brand system created before any creative work begins. If your diabetes or cardiometabolic company plans to go direct-to-patient, we should speak before the funnel gets built.
